Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

179 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
European lipodystrophy registry: background and structure.
von Schnurbein J, Adams C, Akinci B, Ceccarini G, D'Apice MR, Gambineri A, Hennekam RCM, Jeru I, Lattanzi G, Miehle K, Nagel G, Novelli G, Santini F, Santos Silva E, Savage DB, Sbraccia P, Schaaf J, Sorkina E, Tanteles G, Vantyghem MC, Vatier C, Vigouroux C, Vorona E, Araújo-Vilar D, Wabitsch M. von Schnurbein J, et al. Among authors: akinci b. Orphanet J Rare Dis. 2020 Jan 15;15(1):17. doi: 10.1186/s13023-020-1295-y. Orphanet J Rare Dis. 2020. PMID: 31941540 Free PMC article.
A National Multicenter Study of Leptin and Leptin Receptor Deficiency and Systematic Review.
Besci Ö, Fırat SN, Özen S, Çetinkaya S, Akın L, Kör Y, Pekkolay Z, Özalkak Ş, Özsu E, Erdeve ŞS, Poyrazoğlu Ş, Berberoğlu M, Aydın M, Omma T, Akıncı B, Demir K, Oral EA. Besci Ö, et al. Among authors: akinci b. J Clin Endocrinol Metab. 2023 Aug 18;108(9):2371-2388. doi: 10.1210/clinem/dgad099. J Clin Endocrinol Metab. 2023. PMID: 36825860
Familial partial lipodystrophy linked to a novel peroxisome proliferator activator receptor -γ (PPARG) mutation, H449L: a comparison of people with this mutation and those with classic codon 482 Lamin A/C (LMNA) mutations.
Demir T, Onay H, Savage DB, Temeloglu E, Uzum AK, Kadioglu P, Altay C, Ozen S, Demir L, Cavdar U, Akinci B. Demir T, et al. Among authors: akinci b. Diabet Med. 2016 Oct;33(10):1445-50. doi: 10.1111/dme.13061. Epub 2016 Feb 5. Diabet Med. 2016. PMID: 26756202
Diagnostic strategies and clinical management of lipodystrophy.
Foss-Freitas MC, Akinci B, Luo Y, Stratton A, Oral EA. Foss-Freitas MC, et al. Among authors: akinci b. Expert Rev Endocrinol Metab. 2020 Mar;15(2):95-114. doi: 10.1080/17446651.2020.1735360. Expert Rev Endocrinol Metab. 2020. PMID: 32368944 Review.
Complications of lipodystrophy syndromes.
Akinci G, Celik M, Akinci B. Akinci G, et al. Among authors: akinci b. Presse Med. 2021 Nov;50(3):104085. doi: 10.1016/j.lpm.2021.104085. Epub 2021 Oct 30. Presse Med. 2021. PMID: 34728268
Loss of thymidine phosphorylase activity disrupts adipocyte differentiation and induces insulin-resistant lipoatrophic diabetes.
Gautheron J, Lima L, Akinci B, Zammouri J, Auclair M, Ucar SK, Ozen S, Altay C, Bax BE, Nemazanyy I, Lenoir V, Prip-Buus C, Acquaviva-Bourdain C, Lascols O, Fève B, Vigouroux C, Noel E, Jéru I. Gautheron J, et al. Among authors: akinci b. BMC Med. 2022 Mar 28;20(1):95. doi: 10.1186/s12916-022-02296-2. BMC Med. 2022. PMID: 35341481 Free PMC article.
179 results